588 related articles for article (PubMed ID: 18812553)
1. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
2. Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
Sen S; Zhou H; Zhang RD; Yoon DS; Vakar-Lopez F; Ito S; Jiang F; Johnston D; Grossman HB; Ruifrok AC; Katz RL; Brinkley W; Czerniak B
J Natl Cancer Inst; 2002 Sep; 94(17):1320-9. PubMed ID: 12208897
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
4. Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior.
Mobley A; Zhang S; Bondaruk J; Wang Y; Majewski T; Caraway NP; Huang L; Shoshan E; Velazquez-Torres G; Nitti G; Lee S; Lee JG; Fuentes-Mattei E; Willis D; Zhang L; Guo CC; Yao H; Baggerly K; Lotan Y; Lerner SP; Dinney C; McConkey D; Bar-Eli M; Czerniak B
Sci Rep; 2017 Jan; 7():40714. PubMed ID: 28102366
[TBL] [Abstract][Full Text] [Related]
5. A new approach in the diagnosis and follow-up of bladder cancer. FISH analysis of urine, bladder washings, and tumors.
Meloni AM; Peier AM; Haddad FS; Powell IJ; Block AW; Huben RP; Todd I; Potter W; Sandberg AA
Cancer Genet Cytogenet; 1993 Dec; 71(2):105-18. PubMed ID: 8281514
[TBL] [Abstract][Full Text] [Related]
6. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
[TBL] [Abstract][Full Text] [Related]
7. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
8. Detection of Bladder Cancer in Urine Sediments by a Novel Multicolor Fluorescence In Situ Hybridization (Quartet) Test.
Zhang S; Wang Y; Bondaruk J; Majewski T; Yao H; Lee S; Lee JG; Cogdell D; Lotan Y; Dinney C; Wei P; Baggerly K; Czerniak B
Eur Urol Focus; 2019 Jul; 5(4):664-675. PubMed ID: 29428551
[TBL] [Abstract][Full Text] [Related]
9. Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells.
Chung CM; Man C; Jin Y; Jin C; Guan XY; Wang Q; Wan TS; Cheung AL; Tsao SW
Mol Carcinog; 2005 Jul; 43(3):165-74. PubMed ID: 15880741
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.
Lentini L; Amato A; Schillaci T; Di Leonardo A
BMC Cancer; 2007 Nov; 7():212. PubMed ID: 17999753
[TBL] [Abstract][Full Text] [Related]
11. Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.
Fraizer GC; Diaz MF; Lee IL; Grossman HB; Sen S
Int J Oncol; 2004 Dec; 25(6):1631-9. PubMed ID: 15547700
[TBL] [Abstract][Full Text] [Related]
12. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
[TBL] [Abstract][Full Text] [Related]
14. Centrosomal abnormality is common in and a potential biomarker for bladder cancer.
Jiang F; Caraway NP; Sabichi AL; Zhang HZ; Ruitrok A; Grossman HB; Gu J; Lerner SP; Lippman S; Katz RL
Int J Cancer; 2003 Sep; 106(5):661-5. PubMed ID: 12866024
[TBL] [Abstract][Full Text] [Related]
15. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
Wild PJ; Fuchs T; Stoehr R; Zimmermann D; Frigerio S; Padberg B; Steiner I; Zwarthoff EC; Burger M; Denzinger S; Hofstaedter F; Kristiansen G; Hermanns T; Seifert HH; Provenzano M; Sulser T; Roth V; Buhmann JM; Moch H; Hartmann A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1798-806. PubMed ID: 19454613
[TBL] [Abstract][Full Text] [Related]
16. Bradeion (SEPT4) as a urinary marker of transitional cell bladder cancer: a real-time polymerase chain reaction study of gene expression.
Bongiovanni L; Pirozzi F; Guidi F; Orsini M; Chiurazzi P; Bassi PF; Racioppi M
J Urol; 2012 Jun; 187(6):2223-7. PubMed ID: 22503047
[TBL] [Abstract][Full Text] [Related]
17. Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer.
de Martino M; Shariat SF; Hofbauer SL; Lucca I; Taus C; Wiener HG; Haitel A; Susani M; Klatte T
World J Urol; 2015 Jan; 33(1):105-10. PubMed ID: 24562316
[TBL] [Abstract][Full Text] [Related]
18. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
19. Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.
Otto W; Fritsche HM; Wild PJ; Wieland WF; Hartmann A; Burger M; Hofstädter F; Denzinger S
Pathol Res Pract; 2011 Mar; 207(3):161-3. PubMed ID: 21247708
[TBL] [Abstract][Full Text] [Related]
20. High aurora kinase expression identifies patients with muscle-invasive bladder cancer who have poor survival after neoadjuvant chemotherapy.
Burgess EF; Livasy C; Trufan S; Hartman A; Guerreri R; Naso C; Clark PE; Grigg C; Symanowski J; Raghavan D
Urol Oncol; 2019 Dec; 37(12):900-906. PubMed ID: 31597600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
